查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年奈米生物技术市场预测 - 按类型、治疗方法、技术、用途和地区进行的全球分析
市场调查报告书
商品编码
1358969

2030 年奈米生物技术市场预测 - 按类型、治疗方法、技术、用途和地区进行的全球分析

Nanobiotechnology Market Forecasts to 2030 - Global Analysis By Type (10-100 Nm and 0-10 Nm), Therapeutic (Orthopedic Therapies, Dental Therapies, Cardiac Therapies, Liposomes and Other Therapeutics), Technology, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球奈米生物技术市场规模为1,126.6亿美元，预计到2030年将达到1,869.1亿美元，预测期内年复合成长率为7.5%。

在奈米级层面上对生物系统的研究，通常涉及分子和微粒，被称为奈米生物技术，是奈米技术和生物技术领域的融合。与奈米生物技术同时使用的其他术语包括奈米生物学和生物奈米技术。透过在小于100奈米的尺度上操纵物质来生产和使用材料、设备和系统，统称为「奈米生物技术应用」。在全球范围内，政府和公司正在大力投资奈米生物技术。

根据联合国粮食及农业组织预测，到 2050 年，世界人口预计将超过 97 亿。

慢性病增加

奈米生物技术市场的关键成长促进因素是全球癌症、糖尿病和心血管疾病等慢性病患病的上升。奈米生物技术为某些疾病的常规治疗方法问题提供了更好的解决方案。例如，基于奈米颗粒的药物传输系统可以实现加护治疗，从而减少副作用并改善患者的治疗效果。随着全球慢性病负担的增加，对创造性奈米生物技术解决方案的需求不断增加。

开发成本高

奈米生物技术产品的开发和商业化需要对基础设施、专业设备、人员以及研发活动进行大量投资。然而，奈米生物技术的高开发成本可能会成为一种阻碍力，特别是对于财力有限的新兴企业（SME）而言。为了突破这一障碍，获得资本和投资机会至关重要。

增加奈米生物技术的投资

越来越多的新颖性、原创和未来性的产品正在进行临床试验，这可能会加速全球奈米生物技术市场的发展。世界各地的公司和政府正在大力投资奈米生物技术。此外，许多政府机构正在增加对奈米生物技术研究和进步的投资。公司正积极投资研发，将新产品推向市场。在奈米生物技术领域，这些创新工具正在为公司带来竞争优势。

毒性和长期影响

奈米生物技术利用具有特殊性能和潜在危险的奈米级材料。因此，法规机构在认证和行销奈米生物技术产品时一直存在担忧。由于对奈米材料毒性及其对人类健康和环境的长期影响的安全担忧，预计将加强审查和审查。因此，这些要素预计将在预测期内阻碍奈米生物技术市场的扩张。

COVID-19 的影响：

COVID-19 的爆发凸显了快速准确诊断以及开发高效能药物和疫苗的重要性。奈米生物技术能够提高诊断测试的敏感性和特异性并增强药物传输系统，在这两个领域都具有重要意义。对医疗保健解决方案的关注可能加速了奈米生物技术产业的扩张。政府和私人投资者可能已将资金和资源转移到与 COVID-19 相关领域的研究和开发。可能会向专注于病毒相关主题的奈米生物技术公司提供更多资金。

预计在预测期内，製药领域将是最大的产业。

预计在预测期内，製药领域将占据最大份额。药品製造和分销使用奈米级材料、设备和程序。此外，该领域有潜力改变药物开发、输送和治疗效果，从而为各种疾病提供更个体化和集中的治疗。

预计整形外科治疗领域在预测期内将经历最高的年复合成长率。

由于奈米材料、药物传输系统和专为整形外科设计的诊断设备的开发取得了重大进展，整形外科治疗领域预计将在预测期内实现有益成长。此外，透过使用奈米颗粒和奈米复合材料等奈米材料，奈米生物技术能够将标靶药物输送到受伤组织，提高治疗的生物利用度并支持组织再生。奈米级影像方式也改善了整形外科疾病的早期检测和监测。

比最大的地区

预计北美在预测期内将占据最大份额。稳定的法规环境为该地区奈米生物技术的发展创造了良好的氛围。美国FDA 和其他法规机构与公司和研究人员密切合作，以确保奈米技术产品的功效和安全性。此外，产业合作和政府的大力支持是该区域市场成功的关键要素。

复合年复合成长率最高的地区：

由于成功的临床试验和最终食品药物管理局(FDA) 批准推动製药和生物技术行业良好的成长前景，预计欧洲将预测最高的成长。区域市场扩张的主要促进因素是对技术先进产品的需求不断增长以及研发设施的扩张。预计有助于区域市场扩张的其他方面包括生物技术部门的扩张、政府投资和配合措施、癌症研究和靶向药物、农业和环境应用以及电子设备和材料领域的奈米技术。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球奈米生物技术市场：按类型

  • 10～100Nm
  • 0～10Nm

第6章全球奈米生物技术市场：依治疗方法

  • 整形外科治疗
  • 牙科治疗
  • 心臟治疗
  • 脂质体
  • 其他治疗方法

第7章全球奈米生物技术市场：依技术分类

  • 奈米粒子
  • 奈米壳
  • 奈米管
  • 其他技术

第8章全球奈米生物技术市场：依用途

  • 基因组学
  • 药物输送
  • 蛋白质体学
  • 药品
  • 粮食和农业
  • 医疗设备
  • 医学研究
  • 其他用途

第9章全球奈米生物技术市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Abbott Laboratories
  • Advanced Nano Products Co., Ltd
  • Altair Nanotechnologies Inc
  • Biosensors International Group, Ltd
  • Bruker Corporation
  • Calando Pharmaceuticals
  • Celgene Corporation
  • Dendritic Nanotechnologies
  • Elan Pharmaceuticals
  • eSpin Technologies, Inc
  • Flamel Technologies
  • Imina Technologies SA
  • Johnson & Johnson
  • Nano Bridging Molecules SA
  • Novartis AG
  • Thermo Fisher Scientific Inc
  • XanTecbioanalytics GmbH
Product Code: SMRC23841

According to Stratistics MRC, the Global Nanobiotechnology Market is accounted for $112.66 billion in 2023 and is expected to reach $186.91 billion by 2030 growing at a CAGR of 7.5% during the forecast period. The study of biological systems at the nanoscale level, often including molecules and microscopic particles, is known as nanobiotechnology and is a blend of the nanotechnology and biotechnology fields. Other terms that are used simultaneously with nanobiotechnology include nanobiology and bionanotechnology. The production and usage of materials, devices, and systems through the manipulation of matter at scales smaller than 100 nanometers are collectively referred to as "nanobiotechnology applications. Globally, governments and businesses are investing heavily in nanobiotechnology.

According to Food & Agriculture Organization, the world population is anticipated to surpass 9.7 billion by 2050.

Market Dynamics:

Driver:

Increased incidence of chronic diseases

A significant growth driver for the nanobiotechnology market is the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular problems, around the world. Better solutions to problems with conventional therapies for certain illnesses are provided by nanobiotechnology. For instance, focused therapy is made possible by nanoparticle-based drug delivery systems, which also reduce side effects and enhance patient outcomes. The need for creative nanobiotechnology solutions is growing as the burden of chronic diseases increases globally.

Restraint:

High development expenses

Nanobiotechnology products require large investments in infrastructure, specialized equipment, staff, and research and development activities in order to be developed and commercialized. However, nanobiotechnology's high development costs might be a deterrent, especially for startups or small and medium-sized businesses (SMEs) with restricted funding sources. To break through this barrier, access to capital and investment possibilities is essential.

Opportunity:

Increasing investments in nanobiotechnology

A rise in the quantity of novel, inventive, and promising products undergoing clinical trials will accelerate the development of the global nanobiotechnology market. Businesses and governments around the world are making significant investments in nanobiotechnology. Additionally, many government organizations have increased the amount of money that is invested in the study and advancement of nanobiotechnology. To bring novel products to market, businesses are actively investing in research and development. In the nanobiotechnology sector, these innovative tools give businesses a competitive advantage.

Threat:

Toxicity and long term impacts

Nanobiotechnology makes use of materials at the nanoscale, which have special qualities and potential hazards. Because of this, regulatory bodies have been concerned while certifying and releasing nanobiotechnology products for sale. It is anticipated that increased scrutiny and oversight will be required due to safety concerns over the toxicity and long-term impacts of nanomaterials on human health and the environment. Thus, during the course of the forecast period, these factors are anticipated to hinder the expansion of the nanobiotechnology market.

COVID-19 Impact:

The COVID-19 epidemic has highlighted the significance of quick and precise diagnosis as well as the creation of efficient medications and vaccinations. With the ability to increase the sensitivity and specificity of diagnostic tests and enhance drug delivery systems, nanobiotechnology is significant in both fields. The focus on healthcare solutions may have accelerated the expansion of the nanobiotechnology industry. Funds and resources may have been transferred by governments and private investors to research and development in COVID-19-related fields. There may have been more funding available for nanobiotechnology companies focusing on virus-related topics.

The pharmaceuticals segment is expected to be the largest during the forecast period

Pharmaceuticals segment is expected to hold largest share over the projection period. In the manufacturing and distribution of pharmaceutical products, nanoscale materials, devices, and procedures are used. Additionally, this area has the potential to transform medication development, delivery, and therapeutic efficacy, enabling more individualized and focused treatments for a range of illnesses.

The orthopedic therapies segment is expected to have the highest CAGR during the forecast period

Due to significant advances in the creation of nanomaterials, drug delivery systems, and diagnostic instruments specifically designed for orthopedic purposes, the orthopedic therapies segment is anticipated to experience profitable growth over the course of the projected period. Additionally, through the use of nanomaterials like nanoparticles and nanocomposites, nanobiotechnology enables targeted drug delivery to injured tissues, improves the bioavailability of treatments, and supports tissue regeneration. The early detection and monitoring of orthopedic disorders are also being improved by nanoscale imaging and diagnostic methods.

Region with largest share:

North America is expected to hold largest share over the projection period. A stable regulatory environment created a favorable atmosphere for the development of nanobiotechnology in the region. The FDA and other regulatory bodies in the US collaborated closely with businesses and researchers to guarantee the efficacy and safety of nanotech products. Additionally, industry collaboration and robust government support are key factors in the regional market's success.

Region with highest CAGR:

Due to favorable growth prospects for the pharmaceutical and biotechnology industries brought on by successful clinical trials and eventual Food and Drug Administration (FDA) certification, Europe is expected to have the highest growth. The main drivers of regional market expansion are the increasing demand for technologically advanced products and well-developed R&D facilities. Other aspects that are anticipated to contribute to regional market expansion include the expanding biotechnology sector, government investments and efforts, cancer research and targeted medicines, agriculture and environmental applications, and nanotechnology in electronics and materials.

Key players in the market:

Some of the key players in Nanobiotechnology market include: Abbott Laboratories, Advanced Nano Products Co., Ltd, Altair Nanotechnologies Inc, Biosensors International Group, Ltd, Bruker Corporation, Calando Pharmaceuticals, Celgene Corporation, Dendritic Nanotechnologies, Elan Pharmaceuticals, eSpin Technologies, Inc, Flamel Technologies, Imina Technologies SA, Johnson & Johnson, Nano Bridging Molecules SA, Novartis AG, Thermo Fisher Scientific Inc and XanTecbioanalytics GmbH.

Key Developments:

In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes.

Types Covered:

  • 10-100 Nm
  • 0-10 Nm

Therapeutics Covered:

  • Orthopedic Therapies
  • Dental Therapies
  • Cardiac Therapies
  • Liposomes
  • Other Therapeutics

Technologies Covered:

  • Nanoparticles
  • Nanoshells
  • Nanotubes
  • Other Technologies

Applications Covered:

  • Genomics
  • Drug Delivery
  • Proteomics
  • Pharmaceuticals
  • Food and Agriculture
  • Medical Devices
  • Medical Research
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nanobiotechnology Market, By Type

  • 5.1 Introduction
  • 5.2 10-100 Nm
  • 5.3 0-10 Nm

6 Global Nanobiotechnology Market, By Therapeutic

  • 6.1 Introduction
  • 6.2 Orthopedic Therapies
  • 6.3 Dental Therapies
  • 6.4 Cardiac Therapies
  • 6.5 Liposomes
  • 6.6 Other Therapeutics

7 Global Nanobiotechnology Market, By Technology

  • 7.1 Introduction
  • 7.2 Nanoparticles
  • 7.3 Nanoshells
  • 7.4 Nanotubes
  • 7.5 Other Technologies

8 Global Nanobiotechnology Market, By Application

  • 8.1 Introduction
  • 8.2 Genomics
  • 8.3 Drug Delivery
  • 8.4 Proteomics
  • 8.5 Pharmaceuticals
  • 8.6 Food and Agriculture
  • 8.7 Medical Devices
  • 8.8 Medical Research
  • 8.9 Other Applications

9 Global Nanobiotechnology Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Advanced Nano Products Co., Ltd
  • 11.3 Altair Nanotechnologies Inc
  • 11.4 Biosensors International Group, Ltd
  • 11.5 Bruker Corporation
  • 11.6 Calando Pharmaceuticals
  • 11.7 Celgene Corporation
  • 11.8 Dendritic Nanotechnologies
  • 11.9 Elan Pharmaceuticals
  • 11.10 eSpin Technologies, Inc
  • 11.11 Flamel Technologies
  • 11.12 Imina Technologies SA
  • 11.13 Johnson & Johnson
  • 11.14 Nano Bridging Molecules SA
  • 11.15 Novartis AG
  • 11.16 Thermo Fisher Scientific Inc
  • 11.17 XanTecbioanalytics GmbH

List of Tables

  • Table 1 Global Nanobiotechnology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 4 Global Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 5 Global Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 6 Global Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 7 Global Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 8 Global Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 9 Global Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 10 Global Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 11 Global Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 12 Global Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 13 Global Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 14 Global Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 15 Global Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 16 Global Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 18 Global Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 19 Global Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 20 Global Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 21 Global Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 22 Global Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 23 Global Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 24 Global Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 North America Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 North America Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 28 North America Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 29 North America Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 30 North America Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 31 North America Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 32 North America Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 33 North America Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 34 North America Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 35 North America Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 36 North America Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 37 North America Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 38 North America Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 39 North America Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 40 North America Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 North America Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 42 North America Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 43 North America Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 44 North America Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 45 North America Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 46 North America Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 47 North America Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 48 North America Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 49 Europe Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 51 Europe Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 52 Europe Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 53 Europe Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 54 Europe Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 55 Europe Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 56 Europe Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 57 Europe Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 58 Europe Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 59 Europe Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 60 Europe Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 61 Europe Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 62 Europe Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 63 Europe Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 64 Europe Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 65 Europe Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 66 Europe Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 67 Europe Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 68 Europe Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 69 Europe Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 70 Europe Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 71 Europe Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 72 Europe Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 73 Asia Pacific Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 75 Asia Pacific Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 76 Asia Pacific Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 77 Asia Pacific Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 78 Asia Pacific Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 79 Asia Pacific Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 80 Asia Pacific Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 81 Asia Pacific Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 82 Asia Pacific Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 83 Asia Pacific Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 84 Asia Pacific Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 85 Asia Pacific Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 86 Asia Pacific Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 87 Asia Pacific Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 88 Asia Pacific Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 89 Asia Pacific Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 90 Asia Pacific Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 91 Asia Pacific Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 92 Asia Pacific Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 93 Asia Pacific Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 94 Asia Pacific Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 95 Asia Pacific Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 96 Asia Pacific Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 South America Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 99 South America Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 100 South America Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 101 South America Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 102 South America Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 103 South America Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 104 South America Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 105 South America Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 106 South America Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 107 South America Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 108 South America Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 109 South America Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 110 South America Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 111 South America Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 112 South America Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 113 South America Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 114 South America Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 115 South America Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 116 South America Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 117 South America Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 118 South America Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 119 South America Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 120 South America Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 121 Middle East & Africa Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 123 Middle East & Africa Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 124 Middle East & Africa Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 125 Middle East & Africa Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 126 Middle East & Africa Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 127 Middle East & Africa Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 128 Middle East & Africa Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 130 Middle East & Africa Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 131 Middle East & Africa Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 132 Middle East & Africa Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 133 Middle East & Africa Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 134 Middle East & Africa Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 135 Middle East & Africa Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 136 Middle East & Africa Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 137 Middle East & Africa Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 138 Middle East & Africa Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 139 Middle East & Africa Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 140 Middle East & Africa Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 141 Middle East & Africa Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 142 Middle East & Africa Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 143 Middle East & Africa Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 144 Middle East & Africa Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)